The page is the record's research on the issuer — no analyst, no rating, no view. # EXOZYMES INC. (NASDAQ: EXOZ) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is EXOZYMES INC., listed on NASDAQ under the ticker EXOZ, with ISIN US4618741098. Its LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-NV. The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Nevada. The segment is not on the record. The issuer is listed and not halted. ## The disclosure read The record holds 49 filings in the twelve months to 2026-11-08, across 34 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-11-06 and is a prospectus, 2 days before the record date. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. In the sector the median cadence gap is 5.5 days, the median filings count is 65.5, and the median latency is 4.0 days across 176 issuers. The issuer's 49 filings are below the exchange median of 52 and below the sector median of 65.5. The issuer's 8-day cadence gap is above the exchange median of 6.0 days and above the sector median of 5.5 days. The issuer's 2-day latency is below the exchange median of 5.0 days and below the sector median of 4.0 days. ## Auditor The auditor of record is RBSM LLP, located in Las Vegas, Nevada. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002010788.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/EXOZ (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/EXOZ (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/EXOZ · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp